GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
GSK's enterprise value was $120.20B on Oct 19, 2026, against $113.51B a year earlier. Over the last 5 years it ranged from $87.71B to $147.11B, with a median of $103.36B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $120.20B | +1.5% |
| 2025 | Dec 31, 2025 | $118.41B | +35.0% |
| 2024 | Dec 31, 2024 | $87.71B | -9.6% |
| 2023 | Dec 29, 2023 | $97.04B | -5.6% |
| 2022 | Dec 30, 2022 | $102.82B | -29.3% |
| 2021 | Dec 31, 2021 | $145.50B | +7.6% |
| 2020 | Dec 31, 2020 | $135.27B | -6.0% |
| 2019 | Dec 31, 2019 | $143.85B | +26.1% |
| 2018 | Dec 31, 2018 | $114.04B | +4.3% |
| 2017 | Dec 29, 2017 | $109.38B | +28.5% |
| 2016 | Dec 30, 2016 | $85.12B | – |